Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John Herbert Growdon, M.D.

Co-Author

This page shows the publications co-authored by John Growdon and James Gusella.
Connection Strength

0.225
  1. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol. 2006 Jun; 63(6):826-32.
    View in: PubMed
    Score: 0.083
  2. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med. 2008 Nov 05; 6:32.
    View in: PubMed
    Score: 0.025
  3. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord. 2008 Aug 15; 23(11):1596-601.
    View in: PubMed
    Score: 0.024
  4. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet. 2008 Aug; 124(1):95-9.
    View in: PubMed
    Score: 0.024
  5. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 2003 Dec 09; 61(11):1557-61.
    View in: PubMed
    Score: 0.017
  6. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet. 2002 May; 70(5):1089-95.
    View in: PubMed
    Score: 0.016
  7. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology. 2001 Sep 25; 57(6):1124-6.
    View in: PubMed
    Score: 0.015
  8. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. Ann N Y Acad Sci. 1996 Dec 16; 802:35-41.
    View in: PubMed
    Score: 0.011
  9. No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. Genomics. 1996 Apr 01; 33(1):53-6.
    View in: PubMed
    Score: 0.010
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.